Thu, August 1, 2024

Charles Duncan Maintained (VNDA) at Buy with Increased Target to $13 on, Aug 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-13-on-aug-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Duncan of Cantor Fitzgerald, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Buy with Increased Target from $11 to $13 on, Aug 1st, 2024.

Charles, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources